These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 19934084)
1. Urinary properdin excretion is associated with intrarenal complement activation and poor renal function. Siezenga MA; van der Geest RN; Mallat MJ; Rabelink TJ; Daha MR; Berger SP Nephrol Dial Transplant; 2010 Apr; 25(4):1157-61. PubMed ID: 19934084 [TBL] [Abstract][Full Text] [Related]
2. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients. Lammerts RGM; Eisenga MF; Alyami M; Daha MR; Seelen MA; Pol RA; van den Born J; Sanders JS; Bakker SJL; Berger SP Front Immunol; 2019; 10():2511. PubMed ID: 31736953 [TBL] [Abstract][Full Text] [Related]
3. Pitfalls in urinary complement measurements. van der Pol P; de Vries DK; van Gijlswijk DJ; van Anken GE; Schlagwein N; Daha MR; Aydin Z; de Fijter JW; Schaapherder AF; van Kooten C Transpl Immunol; 2012 Aug; 27(1):55-8. PubMed ID: 22709941 [TBL] [Abstract][Full Text] [Related]
4. Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage. Nagamachi S; Ohsawa I; Suzuki H; Sato N; Inoshita H; Hisada A; Honda D; Shimamoto M; Shimizu Y; Horikoshi S; Tomino Y BMC Nephrol; 2014 May; 15():82. PubMed ID: 24885016 [TBL] [Abstract][Full Text] [Related]
5. Complement activation by tubular cells is mediated by properdin binding. Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294 [TBL] [Abstract][Full Text] [Related]
6. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC]. Kusunoki Y Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Honkanen E; Teppo AM; Meri S; Lehto T; Grönhagen-Riska C Nephrol Dial Transplant; 1994; 9(11):1553-9. PubMed ID: 7870341 [TBL] [Abstract][Full Text] [Related]
8. Urinary protein and enzyme excretion as markers of tubular damage. D'Amico G; Bazzi C Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):639-43. PubMed ID: 14564202 [TBL] [Abstract][Full Text] [Related]
9. Complement activation products in the urine from proteinuric patients. Morita Y; Ikeguchi H; Nakamura J; Hotta N; Yuzawa Y; Matsuo S J Am Soc Nephrol; 2000 Apr; 11(4):700-707. PubMed ID: 10752529 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883 [TBL] [Abstract][Full Text] [Related]
12. [Terminal complement complex (TCC) levels in urine in patients with renal diseases]. Yasuda K Hokkaido Igaku Zasshi; 2001 Mar; 76(2):71-84. PubMed ID: 11344904 [TBL] [Abstract][Full Text] [Related]
13. Renal disorders involved in the pathophysiology of urinary excretion of a-1 microglobulin in patients with glomerulopathies. Romão EA; Coimbra TM; Costa RS; Vieira Neto OM; Reis MA; Rodrigues Júnior AL; Ribeiro RA; Ravinal RC; Dantas M Clin Nephrol; 2009 Dec; 72(6):473-81. PubMed ID: 19954725 [TBL] [Abstract][Full Text] [Related]
14. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578 [TBL] [Abstract][Full Text] [Related]
15. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647 [TBL] [Abstract][Full Text] [Related]
16. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871 [TBL] [Abstract][Full Text] [Related]
17. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]. Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042 [TBL] [Abstract][Full Text] [Related]
18. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor. Triolo G; Giardina E; Casiglia D; Scarantino G; Bompiani GD Clin Exp Immunol; 1991 Apr; 84(1):53-8. PubMed ID: 2015712 [TBL] [Abstract][Full Text] [Related]
19. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Fernández-Fresnedo G; Plaza JJ; Sánchez-Plumed J; Sanz-Guajardo A; Palomar-Fontanet R; Arias M Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of urinary factor H excretion in patients with idiopathic membranous nephropathy]. Endo M; Fuke Y; Ohi H; Satomura A; Fukuda N; Fujita T; Matsumoto K Nihon Jinzo Gakkai Shi; 2007; 49(5):499-504. PubMed ID: 17695812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]